Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation

被引:310
作者
Tan, J
Town, T
Paris, D
Mori, T
Suo, ZM
Crawford, F
Mattson, MP
Flavell, RA
Mullan, M
机构
[1] Univ S Florida, Roskamp Inst, Tampa, FL 33613 USA
[2] Univ Kentucky, Sanders Brown Res Ctr Aging, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[4] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA
关键词
D O I
10.1126/science.286.5448.2352
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Alzheimer's disease (AD) has a substantial inflammatory component, and activated microglia may play a central role in neuronal degeneration, CD40 expression was increased on cultured microglia treated with freshly solublized amyloid-beta (A beta, 500 nanomolar) and on microglia from a transgenic murine model of AD (Tg APP(sw)). Increased tumor necrosis factor alpha production and induction of neuronal injury occurred when A beta-stimulated microglia were treated with CD40 ligand (CD40L), Microglia from Tg APP(sw) mice deficient for CD4OL demonstrated reduction in activation, suggesting that the CD40-CD40L interaction is necessary for A beta-induced microglial activation. Finally, abnormal tau phosphorylation was reduced in Tg APP(sw) animals deficient for CD40L, suggesting that the CD40-CD40L interaction is an early event in AD pathogenesis.
引用
收藏
页码:2352 / 2355
页数:4
相关论文
共 28 条
  • [1] Castillo GM, 1997, J NEUROCHEM, V69, P2452
  • [2] Combs CK, 1999, J NEUROSCI, V19, P928
  • [3] CD40 is functionally expressed on human keratinocytes
    Denfeld, RW
    Hollenbaugh, D
    Fehrenbach, A
    Weiss, JM
    vonLeoprechting, A
    Mai, B
    Voith, U
    Schopf, E
    Aruffo, A
    Simon, JC
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (10) : 2329 - 2334
  • [4] Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience .15.
    Ellis, RJ
    Olichney, JM
    Thal, LJ
    Mirra, SS
    Morris, JC
    Beekly, D
    Heyman, A
    [J]. NEUROLOGY, 1996, 46 (06) : 1592 - 1596
  • [5] Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment
    Genis, I
    Fisher, A
    Michaelson, DM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) : 206 - 213
  • [6] CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
    Henn, V
    Slupsky, JR
    Gräfe, M
    Anagnostopoulos, I
    Förster, R
    Müller-Berghaus, G
    Kroczek, RA
    [J]. NATURE, 1998, 391 (6667) : 591 - 594
  • [7] EARLY ALZHEIMER-DISEASE-LIKE HISTOPATHOLOGY INCREASES IN FREQUENCY WITH AGE IN MICE TRANSGENIC FOR BETA-APP751
    HIGGINS, LS
    RODEMS, JM
    CATALANO, R
    QUON, D
    CORDELL, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) : 4402 - 4406
  • [8] EXPRESSION OF FUNCTIONAL CD40 BY VASCULAR ENDOTHELIAL-CELLS
    HOLLENBAUGH, D
    MISCHELPETTY, N
    EDWARDS, CP
    SIMON, JC
    DENFELD, RW
    KEINER, PA
    ARUFFO, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (01) : 33 - 40
  • [9] Correlative memory deficits, A beta elevation, and amyloid plaques in transgenic mice
    Hsiao, K
    Chapman, P
    Nilsen, S
    Eckman, C
    Harigaya, Y
    Younkin, S
    Yang, FS
    Cole, G
    [J]. SCIENCE, 1996, 274 (5284) : 99 - 102
  • [10] AGE-RELATED CNS DISORDER AND EARLY DEATH IN TRANSGENIC FVB/N MICE OVEREXPRESSING ALZHEIMER AMYLOID PRECURSOR PROTEINS
    HSIAO, KK
    BORCHELT, DR
    OLSON, K
    JOHANNSDOTTIR, R
    KITT, C
    YUNIS, W
    XU, S
    ECKMAN, C
    YOUNKIN, S
    PRICE, D
    IADECOLA, C
    CLARK, HB
    CARLSON, G
    [J]. NEURON, 1995, 15 (05) : 1203 - 1218